DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Onyx Biotec Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 2 hrs ago·13 Oct 2026, 1:23 pm

Onyx Biotec

Onyx Biotec Limited has informed the stock exchanges that it has received a Certificate under SEBI (Depositories and Participants) Regulations, 2018. This document confirms that the company has complied with the regulatory requirements for the issuance of securities, including shares and warrants, through the depository system. The certificate is a standard procedural step for companies issuing new securities.

For investors, this development is largely procedural and does not indicate any new business activity or financial results. It ensures that the company's shareholding structure is compliant with market regulations. This compliance is a prerequisite for the issuance of new securities, which can sometimes be a precursor to fundraising or employee stock option plans.

Investors should monitor the company's future announcements for any specific details regarding the purpose of this compliance. While this is a routine regulatory update, it reinforces the company's adherence to SEBI norms. Watch for any upcoming fundraising plans or corporate actions that might be linked to this compliance status.